Combining #GeneEditing and RNAi can enhance #AdvancedTherapies. Read our recent article for BioInsights where Vlad Seitan, CSO, discusses GEiGS technology and its advantages in iPSC-derived allogeneic cell therapy. @CGT_Insights laverocktx.com/exploring-the-…
Laverock Therapeutics
@LaverockTx
Developing the next generation of programmable #cell #therapies. With dedicted labs in the UK, Laverock Therapeutics has an experienced and knowledgeable team.
18 Following 15 Followers 17 Posts
Latest posts 5
We’re pleased to announce £1m funding via the @InnovateUK Investor Partnerships Future Economy programme with support from @UKI2S to progress our immune effector cell therapeutic programme aiming to combat hard-to-treat cancers.
laverocktx.com/laverock-thera… @UKRI_News
laverocktx.com/laverock-thera… @UKRI_News
We’re at #ESGCT2023 this week discussing how GEiGS technology enables the development of products with improved efficacy, safety and accessibility. Interested in partnering?
Meet us at one of our posters P516, P582 and P706.
laverocktx.com/laverock-thera… @ESGCT
Meet us at one of our posters P516, P582 and P706.
laverocktx.com/laverock-thera… @ESGCT
Will you be at #ESGCT2023 next week?
We’ll be presenting a series of posters looking at the therapeutic applications of our #GeneEditing technology, get in touch to arrange a meeting at the conference. laverocktx.com/laverock-thera… @ESGCT
We’ll be presenting a series of posters looking at the therapeutic applications of our #GeneEditing technology, get in touch to arrange a meeting at the conference. laverocktx.com/laverock-thera… @ESGCT
What a great first day at #CGMesa23, looking forward to many more engaging discussions over the next two days.
Don’t miss our company presentation at 11am on 12th October. @alliancerm laverocktx.com/laverock-thera… #CellTherapy #GeneTherapy
Don’t miss our company presentation at 11am on 12th October. @alliancerm laverocktx.com/laverock-thera… #CellTherapy #GeneTherapy